HiSiaddi is an innovative foreign trade service provider driven by both technology transformation and export business. We have established a comprehensive service system dubbed "1+2+3+4=1" and can supply D-biotin (Vitamin B7) sourced directly from multiple well-known original manufacturers. As a tech-driven foreign trade enterprise, HiSiaddi has collaborated with manufacturers on multiple technology transformation projects and accurately captured market demands, enabling us to resolve various customized D-biotin requirements for clients. Below is a case study detailing how we delivered a tailor-made D-biotin solution.
For inquiries about customized services, please contact HiSiaddi customer support.
Client: SwissHair Labs (Switzerland) A top-tier Swiss enterprise specializing in beauty and nutritional research, the company develops premium oral hair care tablets, medical-grade skin repair formulations, and salon-exclusive biotin serums. Its products are sold at high-end Swiss pharmacies, five-star EU salons and private medical institutions. The firm adheres to stringent standards including EP 10.0, USP-NF, cGMP, REACH and COSMOS organic certifications, requiring research-grade performance in chiral purity, particle size distribution, thermal stability, solvent residue and bioavailability. It is a high-end technical client with zero-defect quality expectations.
The client developed a new patented sustained-release hair care tablet with customized D-biotin as the core raw material, mandating five strict customized specifications simultaneously:
1. Chiral purity: D-isomer ≥99.8% (standard commercial grade only reaches 98.5%) to eliminate inactive L-isomers;
2. Particle size control: D90 = 8–12 μm (ultra-fine uniform powder) compatible with the micro-dissolution process for sustained-release tablets;
3. Thermal stability: ≥98% activity retention after 10 minutes at 120 °C (standard grade retains merely 85%);
4. Ultra-low impurities: solvent residue ≤10 ppm (ethanol only), heavy metals ≤0.5 ppm, no detectable microorganisms;
5. Custom packaging: light-proof sterile aluminum foil bags filled with inert gas, attached with tri-lingual traceability labels (German, English, French) for Switzerland.
The client previously partnered with three major domestic biotin manufacturers, yet all declined the order due to inability to meet all five specifications simultaneously, insufficient process capacity, excessive customization costs and unguaranteed lead times, delaying the launch of its new product line. The client urgently commissioned HiSiaddi to complete customized R&D, pilot production, mass manufacturing and delivery within 45 days, with full EU compliance and consistent long-term supply guaranteed.
HiSiaddi’s technical and commercial teams jointly conducted an assessment and identified four technically and economically challenging bottlenecks unattainable for ordinary manufacturers:
Conventional chemically synthesized D-biotin only achieves 98.5%–99.0% chiral purity, with residual L-isomers hard to separate. Fermentation-based production delivers slightly higher purity (99.2%–99.5%) yet introduces complex impurities and higher costs. The client’s requirement of ≥99.8% purity demands exclusive chiral separation technology and multi-stage recrystallization purification—equipment and proprietary formulas unavailable to general manufacturers.
Standard biotin boasts a D90 particle size of 30–50 μm with coarse, uneven particles incompatible with sustained-release micro-dissolution. The client’s D90 requirement of 8–12 μm with a span ≤1.5 necessitates low-temperature jet milling, precision classification and anti-agglomeration treatment. Such equipment requires substantial capital investment, and process parameters are difficult to stabilize, often leading to low yields below 60% from over-fine agglomeration or inconsistent coarse particles.
D-biotin decomposes readily above 60 °C with reduced activity; standard products retain only 85% activity after 10 minutes at 120 °C. Achieving ≥98% retention requires molecular encapsulation and an antioxidant composite formula that preserves biological activity—an R&D capability absent at most regular manufacturers, which cannot accommodate the high-temperature tableting process for sustained-release tablets.
Customized production demands exclusive production lines, flexible small-batch manufacturing, full sterile control and multi-lingual compliance documentation, typically driving costs up by 30%–40% and extending lead times beyond 60 days. The client required a cost premium capped at 15% above standard pricing, delivery within 45 days and full EU compliance—an equilibrium of quality, cost and lead time unachievable for ordinary factories, which refused to take the order.
HiSiaddi assembled a dedicated project team consisting of biotin R&D specialists, process engineers, compliance officers and a project director, partnering with Jiangsu Caiwei Bio, China’s leading manufacturer with exclusive research-grade biotin customization capacity. We adopted a four-dimensional solution of technical customization, process optimization, flexible production scheduling and pre-emptive compliance review to complete full delivery within the 45-day deadline.
Process Upgrade: Abandon standard synthetic routes and adopt a proprietary workflow of "crude fermentation extraction + enzymatic chiral separation + low-temperature recrystallization + membrane separation purification" to precisely strip L-isomers. Parameter Control: Separation temperature maintained at 5±1 °C, recrystallization pH stabilized at 5.5±0.2, and precise membrane molecular weight cutoff to ensure D-isomer ≥99.8%. Testing & Verification: Each batch undergoes HPLC chiral column testing with an EP-standard chiral purity report confirming undetectable L-isomers (<0.1%).
Equipment Modification: Deploy dedicated -15 °C low-temperature jet mill and precision classifier to avoid thermal activity degradation and particle agglomeration. Parameter Calibration: Milling pressure set at 0.6 MPa, classification speed at 12,000 rpm and feed rate at 5 kg/h; 12 rounds of iterative testing finalized optimal parameters. Quality Control: Laser particle size analysis for every batch guarantees D90 = 9.5±1 μm with a span of 1.2, delivering excellent flowability without agglomeration for seamless sustained-release tablet processing.
Formulation Development: Adopt a food-grade maltodextrin + vitamin E composite encapsulation system to form a nanoscale protective film on D-biotin surfaces, isolating heat and oxygen. Process Adaptation: Encapsulation held at 45 °C with a 30-minute curing cycle to preserve full biological activity. Stability Testing: Third-party laboratory testing recorded 98.5% activity retention after 10 minutes at 120 °C, exceeding client requirements and fully compatible with high-temperature tableting for sustained-release tablets.
Flexible Scheduling: Reserve an exclusive dedicated production line with priority scheduling; adopt small-batch multi-run production (50 kg per batch) to complete 200 kg customized output within 45 days. Cost Optimization: Streamline workflows, recycle waste materials and bulk purchase auxiliary ingredients to cap the customization premium at only 12% above standard pricing, undercutting the client’s 15% budget ceiling. Pre-emptive Compliance: Parallelize preparation of REACH statements, COSMOS organic certifications, dual EP/USP COAs, tri-lingual label design and sterile custom packaging. Full compliance documentation is delivered alongside finished goods without additional waiting periods.
Full third-party laboratory testing by the client confirmed all metrics met or surpassed requirements:
· Chiral purity: 99.85% D-isomer with undetectable L-isomers;
· Particle size: D90 = 9.2 μm, span = 1.18, ultra-fine uniform powder with superior flowability;
· Thermal stability: 98.7% activity retention after 10 minutes at 120 °C;
· Impurities: ethanol solvent residue 8 ppm, heavy metals (lead/arsenic/mercury) ≤0.3 ppm, zero microbial detection;
· Packaging: light-proof sterile nitrogen-filled aluminum foil bags with complete compliant tri-lingual traceability labels. All specifications were fully satisfied, perfectly matching the production of the client’s patented sustained-release tablets.
· Lead time: Production, testing, packaging and delivery fully completed in 42 days, 3 days ahead of schedule;
· Cost: Final pricing carried a 12% premium over standard rates, lower than the client’s expected 15% surcharge for exceptional cost-performance.
The complete compliance document package (EP COA, USP test reports, REACH statements, COSMOS certifications, cGMP audit reports and tri-lingual label filings) passed Swiss pharmaceutical and EU regulatory reviews without queries or inspections. The client formally awarded HiSiaddi exclusive global agency status for customized D-biotin procurement with the following commitments:
· Annual customized procurement volume: 500 kg (quarterly deliveries of 125 kg);
· Deepened collaboration: Entrust HiSiaddi to develop three premium derivative products: zinc/selenium-fortified composite biotin, microencapsulated biotin and water-soluble biotin;
· Technical sharing: Share sustained-release tablet formulation data with HiSiaddi to jointly optimize raw material-formula compatibility.
The customized D-biotin enabled the client’s patented oral hair care sustained-release tablets to launch successfully. Driven by high activity, thermal stability and bioavailability, the product captured 18% of Switzerland’s high-end hair supplement market within three months of launch, outperforming competitors and significantly elevating the client’s brand influence.
The core pain point for foreign mid-to-high-end clients sourcing customized D-biotin (Vitamin B7) lies in balancing extreme technical requirements, customized manufacturing and compliance costs. Ordinary manufacturers are constrained by limited technology, equipment and R&D capacity, unable to overcome barriers around chiral purity, particle size and thermal stability while reconciling costs and lead times, resulting in unfulfillable custom orders.
With over a decade of deep expertise in vitamin raw materials, top-tier factory partnerships, specialized technical teams and end-to-end compliance capabilities, HiSiaddi collaborated with leading manufacturers to resolve three core technical bottlenecks, optimize flexible production and conduct pre-emptive compliance reviews. We delivered fully customized products within the 45-day timeline and budget, meeting the client’s rigorous quality standards and supporting their expansion into premium markets.
For top-tier mid-to-high-end clients, a one-stop partner delivering "technical customization, production execution and compliance support" delivers far greater value than a mere supplier. This core competitive advantage has allowed HiSiaddi to build deep ties with premium EU clients across Switzerland, Germany and France, establishing our position as China’s benchmark exporter of customized high-grade vitamin raw materials.
For inquiries about customized services, please contact HiSiaddi customer support.
+86-13120989737 
info@hisiaddi.com 
English
